These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35530144)

  • 1. Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain.
    Du F; Cao R; Chen L; Sun J; Shi Y; Fu Y; Hammock BD; Zheng Z; Liu Z; Chen G
    Acta Pharm Sin B; 2022 Mar; 12(3):1377-1389. PubMed ID: 35530144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
    Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
    Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
    Tian Y; Li S; Dong K; Su X; Fu S; Lv X; Duan M; Yang T; Han Y; Hu G; Liu J; Sun Y; Yue H; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Liu Y; Qin M; Gong P; Hou Y; Gao Z; Zhao Y
    Bioorg Chem; 2022 Oct; 127():105898. PubMed ID: 35792317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.
    Chen Y; Sun J; Tong H; Wang J; Cao R; Xu H; Chen L; Morisseau C; Zhang M; Shi Y; Han C; Zhuang J; Jing Y; Liu Z; Hammock BD; Chen G
    J Med Chem; 2024 Feb; 67(3):2095-2117. PubMed ID: 38236416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Çapan İ; Jordan PM; Olğaç A; Çalışkan B; Kretzer C; Werz O; Banoglu E
    ChemMedChem; 2022 Jun; 17(12):e202200137. PubMed ID: 35466565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
    Wagner K; Yang J; Inceoglu B; Hammock BD
    J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of new series of benzamide derivatives containing urea moiety as sEH inhibitors.
    Tian Y; Li S; Yang P; Su X; Liu J; Lv X; Dong K; Yang T; Duan M; Hu G; Yue H; Sun Y; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Hou Y; Gao Z; Zhao Y
    Bioorg Med Chem Lett; 2022 Aug; 70():128805. PubMed ID: 35598794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.
    Wagner K; Inceoglu B; Dong H; Yang J; Hwang SH; Jones P; Morisseau C; Hammock BD
    Eur J Pharmacol; 2013 Jan; 700(1-3):93-101. PubMed ID: 23276668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.
    Lee KS; Liu JY; Wagner KM; Pakhomova S; Dong H; Morisseau C; Fu SH; Yang J; Wang P; Ulu A; Mate CA; Nguyen LV; Hwang SH; Edin ML; Mara AA; Wulff H; Newcomer ME; Zeldin DC; Hammock BD
    J Med Chem; 2014 Aug; 57(16):7016-30. PubMed ID: 25079952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Dual Inhibitors of Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase with Tetrazole Core.
    Mehrandish S; Rezaee E; Sedaghat A; Heidarli E; Naderi N; Tabatabai SA
    Med Chem; 2023; 19(10):1037-1048. PubMed ID: 37464836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases.
    Chen Y; Chen L; Xu H; Cao R; Morisseau C; Zhang M; Shi Y; Hammock BD; Wang J; Zhuang J; Liu Z; Chen G
    J Med Chem; 2023 Feb; 66(4):2979-3009. PubMed ID: 36689364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of 4-benzamidobenzoic Acid hydrazide derivatives as novel soluble epoxide hydrolase inhibitors.
    Rezaee Zavareh E; Hedayati M; Hoghooghi Rad L; Shahhosseini S; Faizi M; Tabatabai SA
    Iran J Pharm Res; 2014; 13(Suppl):51-9. PubMed ID: 24711829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
    Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
    Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Epoxide Hydrolase Inhibitor TPPU Alleviates Nab-Paclitaxel-Induced Peripheral Neuropathic Pain via Suppressing NF-
    Wei X; Jia L; Zhou Y; Li W; Shan C; Zhang S; Zhao Y
    Pain Res Manag; 2023; 2023():9058774. PubMed ID: 36819745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
    Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
    Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
    Takai K; Nakajima T; Takanashi Y; Sone T; Nariai T; Chiyo N; Nakatani S; Ishikawa C; Yamaguchi N; Fujita K; Yamada K
    Bioorg Med Chem; 2014 Mar; 22(5):1548-57. PubMed ID: 24530032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.